Safety and Performance of the SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchors in Shoulder and Hip Arthroscopic Repair
NCT ID: NCT03691298
Last Updated: 2025-01-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
83 participants
OBSERVATIONAL
2018-11-07
2021-05-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement
NCT00208390
POLARSTEM Retrospective Multicenter Study
NCT02680340
Multicentre Prospective Study to Evaluate Long-term Clinical Outcomes of the Sirius Cemented Femoral Stem
NCT02371382
Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty
NCT05369325
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
NCT03806881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hip: The labrum of the hip is a fibrocartilaginous tissue that connects to the bone edge of the acetabulum (the socket of the hip bone), and deepens the acetabular socket while extending coverage of the femoral head; it also aids in hip stabilization. The goal of surgical intervention is to restore normal hip mechanics and treat existing damage.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arthroscopic hip and shoulder repair
SUTUREFIX ULTRA Suture Anchor and SUTUREFIX CURVED Suture Anchor
Fixation device intended to provide secure fixation of soft tissue to bone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SUTUREFIX ULTRA Suture Anchor and SUTUREFIX CURVED Suture Anchor
Fixation device intended to provide secure fixation of soft tissue to bone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject condition meets proposed indication to SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchor
* Subject requiring shoulder or hip arthroscopic labral repair surgery from physical findings, subject symptoms and radiographic finding
* Hip subjects only:
* FAI (Femoroacetabular Impingement)
* Shoulder subjects only:
* Subject with a history of recurrent dislocation/subluxation of the shoulder
Exclusion Criteria
* Women who are pregnant, nursing, or of child-bearing potential who are not utilizing highly effective birth control measures
* Contraindications or hypersensitivity to the use of the SUTUREFIX ULTRA and/or SUTUREFIX CURVED Suture Anchor, or their components (e.g. silicone, polyester). Where material sensitivity is suspected, appropriate tests should be performed and sensitivity ruled out prior to implantation
* Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation
* Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture
* Comminuted bone surface, which would compromise secure anchor fixation
* Hip subjects only:
* Dysplasia latera/central less than 20°
* Shoulder subjects only:
* Glenoid and/or humeral bone loss considered excessive by the treating orthopaedic surgeon
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew Orthopaedics AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura Everson
Role: STUDY_CHAIR
Smith & Nephew Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University Langone Orthopaedic Center
New York, New York, United States
Orthotennessee
Knoxville, Tennessee, United States
CPH Privathospital
Farum, , Denmark
Pihlajalinna Turku Hospital
Turku, , Finland
Azienda Ospedaliera San Camillo Forlanini
Roma, , Italy
Asepeyo Hospital Sant Cugat
Sant Cugat del Vallès, Barcelona, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, , Spain
Queen Alexandra Hospital
Cosham, , United Kingdom
Fortius Clinic
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-5010-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.